Obalon Therapeutics (OBLN) Short Interest Ratio & Short Volume

Short interest is the volume of Obalon Therapeutics shares that have been sold short but have not yet been closed out or covered. As of May 28th, investors have sold 684,300 shares of OBLN short. 8.15% of Obalon Therapeutics' shares are currently sold short. Learn More on Obalon Therapeutics' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.15% of Obalon Therapeutics' floating shares are currently sold short.

Obalon Therapeutics saw a drop in short interest in May. As of May 28th, there was short interest totaling 684,300 shares, a drop of 11.0% from the previous total of 769,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

Obalon Therapeutics currently has issued a total of 10,022,000 shares. Some of Obalon Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Obalon Therapeutics currently has a public float of 8,400,000 shares.

8.15% of Obalon Therapeutics' shares are currently sold short. Here is how the short interest of companies in the sector of "medical" compare to Obalon Therapeutics: Bluejay Diagnostics, Inc. (0.02%), ReShape Lifesciences Inc. (2.34%), Quoin Pharmaceuticals, Ltd. (0.41%), Sintx Technologies, Inc. (2.44%), Dynatronics Co. (0.58%), Tenon Medical, Inc. (1.82%), Nemaura Medical Inc. (0.34%), ProSomnus, Inc. (1.18%), INVO Bioscience, Inc. (0.65%), Minerva Surgical, Inc. (92.12%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Tesla, Inc. ($8.35 billion), AstraZeneca PLC ($7.50 billion), Aon plc ($7.09 billion), Block, Inc. ($6.95 billion), Analog Devices, Inc. ($6.90 billion), Advanced Micro Devices, Inc. ($6.79 billion), Charter Communications, Inc. ($6.18 billion), S&P Global Inc. ($5.54 billion), Sea Limited ($4.96 billion), and Wayfair Inc. ($4.25 billion). View all of the most shorted stocks.

Short selling OBLN is an investing strategy that aims to generate trading profit from Obalon Therapeutics as its price is falling. OBLN shares are trading up $0.01 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for Obalon Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of OBLN, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including OBLN, twice per month. The most recent reporting period available is May, 28 2021.